Cargando…

Surveillance and return to work of healthcare workers following SARS-CoV-2 Omicron variant infection, Sheffield, England, 17 January to 7 February 2022

The SARS-CoV-2 Omicron variant has challenged demands to minimise workplace transmission in healthcare settings while maintaining adequate staffing. Policymakers have shortened COVID-19 isolation periods, although little real-world data have evaluated the utility. Our findings from surveillance of 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Raza, Mohammed, Giri, Prosenjit, Basu, Subhashis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Centre for Disease Prevention and Control (ECDC) 2022
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8971920/ https://www.ncbi.nlm.nih.gov/pubmed/35301977 http://dx.doi.org/10.2807/1560-7917.ES.2022.27.11.2200164

Ejemplares similares

Impact of the Omicron variant on SARS-CoV-2 reinfections in France, March 2021 to February 2022
por: Bastard, Jonathan, et al.
Publicado: (2022)

A case of avian influenza A(H5N1) in England, January 2022
por: Oliver, Isabel, et al.
Publicado: (2022)

Outbreak of pneumococcal pneumonia among shipyard workers in Marseille, France, January to February 2020
por: Cassir, Nadim, et al.
Publicado: (2020)

Risk of severe COVID-19 from the Delta and Omicron variants in relation to vaccination status, sex, age and comorbidities – surveillance results from southern Sweden, July 2021 to January 2022
por: Kahn, Fredrik, et al.
Publicado: (2022)

Vaccine-induced and naturally-acquired protection against Omicron and Delta symptomatic infection and severe COVID-19 outcomes, France, December 2021 to January 2022
por: Suarez Castillo, Milena, et al.
Publicado: (2022)

Molecular epidemiology of the SARS-CoV-2 variant Omicron BA.2 sub-lineage in Denmark, 29 November 2021 to 2 January 2022
por: Fonager, Jannik, et al.
Publicado: (2022)

mRNA vaccine effectiveness against hospitalisation due to severe acute respiratory infection (SARI) COVID-19 during Omicron variant predominance estimated from real-world surveillance data, Slovenia, February to March 2022
por: Grgič Vitek, Marta, et al.
Publicado: (2022)

Post-discharge surveillance and positive virus detection in two medical staff recovered from coronavirus disease 2019 (COVID-19), China, January to February 2020
por: Xing, Yuanyuan, et al.
Publicado: (2020)

Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022
por: Eggink, Dirk, et al.
Publicado: (2022)

First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020
por: Spiteri, Gianfranco, et al.
Publicado: (2020)

Investigation into cases of hepatitis of unknown aetiology among young children, Scotland, 1 January 2022 to 12 April 2022
por: Marsh, Kimberly, et al.
Publicado: (2022)

Wild poliovirus type 3 (WPV3)-shedding event following detection in environmental surveillance of poliovirus essential facilities, the Netherlands, November 2022 to January 2023
por: Duizer, Erwin, et al.
Publicado: (2023)

Reduced risk of hospitalisation among reported COVID-19 cases infected with the SARS-CoV-2 Omicron BA.1 variant compared with the Delta variant, Norway, December 2021 to January 2022
por: Veneti, Lamprini, et al.
Publicado: (2022)

Active tuberculosis screening among the displaced population fleeing Ukraine, France, February to October 2022
por: Guthmann, Jean-Paul, et al.
Publicado: (2023)

Serological and molecular findings during SARS-CoV-2 infection: the first case study in Finland, January to February 2020
por: Haveri, Anu, et al.
Publicado: (2020)

Hepatitis A outbreak associated with consumption of dates, England and Wales, January 2021 to April 2021
por: Garcia Vilaplana, Tatiana, et al.
Publicado: (2021)

Roll-out of SARS-CoV-2 testing for healthcare workers at a large NHS Foundation Trust in the United Kingdom, March 2020
por: Keeley, Alexander J, et al.
Publicado: (2020)

Increase in invasive group A streptococcal infection notifications, England, 2022
por: Guy, Rebecca, et al.
Publicado: (2023)

Prolonged detection of dengue virus RNA in the semen of a man returning from Thailand to Italy, January 2018
por: Lalle, Eleonora, et al.
Publicado: (2018)

Transmission dynamics of SARS-CoV-2 Omicron variant infections in Hangzhou, Zhejiang, China, January-February 2022
por: Xin, Hualei, et al.
Publicado: (2023)

Enhancing epidemiological surveillance of the emergence of the SARS-CoV-2 Omicron variant using spike gene target failure data, England, 15 November to 31 December 2021
por: Blomquist, Paula B, et al.
Publicado: (2022)

Dynamics of a national Omicron SARS-CoV-2 epidemic during January 2022 in England
por: Elliott, Paul, et al.
Publicado: (2022)

Outbreak of hepatitis A associated with men who have sex with men (MSM), England, July 2016 to January 2017
por: Beebeejaun, Kazim, et al.
Publicado: (2017)

Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020
por: Singanayagam, Anika, et al.
Publicado: (2020)

Low SARS-CoV-2 Cq values in healthcare workers with symptomatic COVID-19 infections, regardless of symptom severity, The Netherlands, January to August 2022
por: van Rossum, Carsten, et al.
Publicado: (2023)

Detection of SARS-CoV-2 in young children attending day-care centres in Belgium, May 2020 to February 2022
por: Van Heirstraeten, Liesbet, et al.
Publicado: (2022)

Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018
por: Eyre, David W, et al.
Publicado: (2018)

Acute onset supraclavicular lymphadenopathy coinciding with intramuscular mRNA vaccination against COVID-19 may be related to vaccine injection technique, Spain, January and February 2021
por: Fernández-Prada, María, et al.
Publicado: (2021)

Genomic and epidemiological report of the recombinant XJ lineage SARS-CoV-2 variant, detected in northern Finland, January 2022
por: Lindh, Erika, et al.
Publicado: (2022)

Epidemiological investigation of a case of malaria in a non-endemic area, Campo de Gibraltar, Cadiz, Spain, January 2022
por: Verona Mesia, Boris, et al.
Publicado: (2022)

Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February
por: Grint, Daniel J, et al.
Publicado: (2021)

Whole genome and phylogenetic analysis of two SARS-CoV-2 strains isolated in Italy in January and February 2020: additional clues on multiple introductions and further circulation in Europe
por: Stefanelli, Paola, et al.
Publicado: (2020)

Early impact of the coronavirus disease (COVID-19) pandemic and physical distancing measures on routine childhood vaccinations in England, January to April 2020
por: McDonald, Helen I, et al.
Publicado: (2020)

Persistent detection of Zika virus RNA in semen for six months after symptom onset in a traveller returning from Haiti to Italy, February 2016
por: Nicastri, Emanuele, et al.
Publicado: (2016)

Investigation of an international outbreak of multidrug-resistant monophasic Salmonella Typhimurium associated with chocolate products, EU/EEA and United Kingdom, February to April 2022
por: Larkin, Lesley, et al.
Publicado: (2022)

Ongoing rabies outbreak in dogs of unprecedented scale and human cases in Nelson Mandela Bay Municipality, South Africa, up to 13 February 2022
por: Ravensberg, Matthijs F, et al.
Publicado: (2022)

Sheffield White and Sheffield Black: The Tragedy of Monday
Publicado: (1924)

Infection dynamics in a traveller with persistent shedding of Zika virus RNA in semen for six months after returning from Haiti to Italy, January 2016
por: Barzon, Luisa, et al.
Publicado: (2016)

COVID-19 vaccine effectiveness against severe disease from SARS-CoV-2 Omicron BA.1 and BA.2 subvariants – surveillance results from southern Sweden, December 2021 to March 2022
por: Björk, Jonas, et al.
Publicado: (2022)

Robust antibody responses in 70–80-year-olds 3 weeks after the first or second doses of Pfizer/BioNTech COVID-19 vaccine, United Kingdom, January to February 2021
por: Subbarao, Sathyavani, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_12pubvilqo9mdfp4gmlkc3l55m